Clinical trial Recruiting at 11 sites Observational Ages 18 to 100

Registry for cardioneuroablation in patients with recurrent vasovagal syncope

Official title: National Registry of Cardioneuroablation in Recurrent Reflex Syncope

Run by University Hospital, Bordeaux · NCT06159764 · Data updated 2026-11-12

This study is collecting information to see how well a new treatment called cardioneuroablation works for people with frequent fainting spells caused by vasovagal syncope.

More Bradycardia trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations14 sites (Bron and 13 other locations)
StatusRecruiting
StartedNovember 27, 2024
Main results expectedJanuary 31, 2026
Study endsJanuary 31, 2026
Registry record updatedJune 17, 2025
Trial IDNCT06159764 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 or older with recurrent vasovagal syncope and documented asystolic episodes who are scheduled for a cardioneuroablation procedure.

Probably not a fit

Patients with contraindications to anticoagulation therapy, cardiac CT, or those with intracardiac thrombus will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects data on the effectiveness of cardioneuroablation for treating recurrent vasovagal syncope across multiple centers in France. The study aims to evaluate success rates, compare different techniques, and assist institutions in establishing their own cardioneuroablation programs. By utilizing radiofrequency ablation to target cardiac ganglionated plexi, the registry seeks to answer key questions regarding patient selection, optimal targeting of fat pads, and long-term outcomes of the procedure. The multicenter approach allows for a comprehensive analysis at minimal cost.

Why it matters

Potential benefit: If successful, this registry could improve treatment options and outcomes for patients suffering from recurrent vasovagal syncope.

How similar studies have gone: While cardioneuroablation is an emerging technique, this registry approach is relatively novel and aims to fill gaps in existing knowledge.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 or more
* Recurrent vasovagal syncope (≥2 episodes during the last year) with an asystolic component (≥3 second pause) recorded during a spontaneous episode. The asystole can be related to sinus arrest or paroxysmal AV block.
* Scheduled cardioneuroablation procedure
* Estimated residual battery life ≥ 1 year.
* Patient affiliated to or beneficiary of national health security scheme.
* Patient who have received an information notice and has not objected to the use of their data in the registry.

Exclusion Criteria:

* Contraindication to anticoagulation therapy: major bleeding, risk of major bleeding, severe hepatic disease
* Contraindication to cardiac CT: contrast medium allergies
* Intracardiac thrombus
* Patient detained by judicial or administrative decision.

Where it's running

  • Hôpital Louis Pradel
    Bron, France
    Recruiting
  • CHU Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting
  • Hôpital de la Timone
    Marseille, France
    Recruiting
  • Clinique du Millénaire
    Montpellier, France
    Recruiting
  • Hôpital Pitié-Salpêtriére
    Paris, France
    Recruiting
  • Hôpital européen Georges Pompidou
    Paris, France
    Recruiting
Show 8 more locations
  • Hôpital Haut-Lévèque
    Pessac, France
    Recruiting
  • CHR Pontchaillou
    Rennes, France
    Recruiting
  • Centre cardiologique du Nord
    Saint-Denis, France
    Recruiting
  • Clinique Pasteur
    Toulouse, France
    Recruiting
  • CHU de Toulouse
    Toulouse, France
    Recruiting
  • CHU Lille
    Lille, France
    Not yet recruiting
  • CHU de Montpellier
    Montpellier, France
    Not yet recruiting
  • Institut ARNAULT TZANCK
    Saint-Laurent-du-Var, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.